BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12620907)

  • 1. Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor.
    Lutke Holzik MF; Hoekstra HJ; Mulder NH; Suurmeijer AJ; Sleijfer DT; Gietema JA
    Ann Surg Oncol; 2003 Mar; 10(2):131-5. PubMed ID: 12620907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
    Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
    Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?
    Stomper PC; Kalish LA; Garnick MB; Richie JP; Kantoff PW
    Radiology; 1991 Sep; 180(3):711-4. PubMed ID: 1651526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
    Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
    Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
    Panicek DM; Toner GC; Heelan RT; Bosl GJ
    Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic resection of a residual retroperitoneal tumor mass of nonseminomatous testicular germ cell tumors.
    Oztürk C; van Ginkel RJ; Krol RM; Gietema JA; Hofker HS; Hoekstra HJ
    Surg Endosc; 2012 Feb; 26(2):458-67. PubMed ID: 21938584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
    Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
    J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center.
    Sarkaria IS; Bains MS; Sood S; Sima CS; Reuter VE; Flores RM; Motzer RJ; Bosl GJ; Rusch VW
    J Thorac Oncol; 2011 Jul; 6(7):1236-41. PubMed ID: 21610519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postchemotherapy residual masses in germ cell tumor patients: our experience.
    Morelli F; Tozzi L; Setola P; Bisceglia M; Barbini VR; Maiello E
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii132-6. PubMed ID: 16760276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 12. Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Toyoshima Y; Hara T; Matsui Y; Nagumo Y; Maejima A; Shinoda Y; Komiyama M; Watanabe SI; Fujimoto H
    Ann Surg Oncol; 2018 Nov; 25(12):3668-3675. PubMed ID: 30191415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.
    Kollmannsberger C; Daneshmand S; So A; Chi KN; Murray N; Moore C; Hayes-Lattin B; Nichols C
    J Clin Oncol; 2010 Feb; 28(4):537-42. PubMed ID: 20026807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours.
    Gels ME; Nijboer AP; Hoekstra HJ; Sleijfer DT; Molenaar WM; Plukker JT; Droste JH; Schraffordt Koops H
    Br J Urol; 1997 Feb; 79(2):263-8. PubMed ID: 9052480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
    Aide N; Comoz F; Sevin E
    J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
    Takizawa A; Miura T; Fujinami K; Osada Y
    Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
    Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP
    J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours.
    Napier MP; Naraghi A; Christmas TJ; Rustin GJ
    Br J Cancer; 2000 Nov; 83(10):1274-80. PubMed ID: 11044349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.